Related by context. All words. (Click for frequent words.) 79 Kinase Inhibitor 79 Presents Preclinical Data 79 Present Preclinical Data 79 Anti Tumor 79 Monoclonal Antibody 78 Aptamer 78 Therapeutic Antibody 77 Preclinical Data 77 RNAi Therapeutic 77 Novel Therapeutic 76 Drug Candidate 76 Completes Patient Enrollment 76 Prolongs Survival 76 Systemic Delivery 76 Oligonucleotide 76 Receives Orphan Drug Designation 76 Develop Novel 76 Kinase Inhibitors 76 Initiates Clinical Trial 76 Preclinical Study 75 RNA Interference 75 Tumor Targeting 75 Novel Oral 75 Anti Tumor Activity 75 Recombinant Protein 75 Phase 2b Clinical Trial 75 Patent Covering 75 Files IND 75 Initiates Clinical 75 Gene Silencing 75 RNAi Therapeutics 75 siRNA Delivery 74 Mimetics 74 Clinical Trial Results 74 Metabolic Disease 74 Inflammatory Arthritis 74 Receives Milestone Payment 74 Hsp# Inhibitor 74 Novel Inhibitor 74 Tyrosine Kinase Inhibitor 74 Novel Antibiotic 74 Antisense Drug 73 Immunotherapeutic 73 Shows Promise Against 73 Novel Mechanism 73 Smooth Muscle 73 platform HDL Mimetic 73 Synthetic Peptide 73 Antigen Specific 73 Anticancer Drug 73 Orally Active 73 Cancer Stem Cells 73 Inhibits 73 AnaSpec Introduces 73 Lung Cancer Drug 73 DNA Methylation 73 Initiates Phase II 73 Protein Kinase 73 Recombinant Human 73 Therapeutic Potential 73 Immune Responses 73 Molecular Mechanism 73 Anti Angiogenic 73 Phase 2a Clinical Trial 73 Drug Shows Promise 73 Clinical Outcome 73 Collaborators Publish 73 Inflammatory Diseases 73 Demonstrates Potential 73 Phase IIb Clinical Trial 73 Receives Orphan Drug 73 Meets Primary Endpoint 73 Neuroprotection 73 Successfully Completes Phase 73 Respiratory Virus 73 Mouse Model 72 Reports Preclinical Data 72 Preclinical Development 72 rxRNA 72 Initiates Phase III 72 Investigational Compound 72 Osteoporosis Treatment 72 Protein Synthesis 72 Antiangiogenic 72 Anti Inflammatory 72 Oligonucleotides 72 Biomolecules 72 Therapeutic Vaccines 72 Aurora Kinase 72 Protein Expression 72 Antitumor Activity 72 Develops Novel 72 FDA Okays 72 Mutagenesis 72 Antitumor 72 Chemotherapeutic Agents 72 Study Evaluating 72 Mouse Models 72 Nuclear Receptors 72 Conjugated 72 Inflammatory Disease 72 Low Dose 72 Phase 2a Trial 72 Autoimmune Disease 72 Initiates Enrollment 72 Lupus Drug 72 Researchers Identify 72 Angiogenic 72 Cancer Vaccines 72 Anticancer Agent 72 Phase 2b Trial 72 Receptor Agonist 72 Presents Positive 72 Prodrug 72 Signaling Pathway 72 Factor Receptor 72 Submits NDA 72 Collaborators Present 72 Novel Therapies 71 Modulates 71 Dendritic Cells 71 Lentiviral 71 Therapeutic Antibodies 71 Therapeutic Vaccine 71 Molecular Basis 71 Exclusive License 71 Magnetic Nanoparticles 71 JAK Inhibitor 71 Vaccine Adjuvants 71 Receives Approvable Letter 71 HDAC Inhibitor 71 pralatrexate injection folate analogue 71 Antibody Discovery 71 Scientists Identify 71 Extracellular Matrix 71 Transcription Factor 71 Immunomedics Announces 71 Licenses Novel 71 Novel Vaccine 71 Transdermal Patch 71 IND Application 71 Breast Cancer Cells 71 JAK2 Inhibitor 71 Protein Biomarker 71 Pharmacokinetic Study 71 Improves Survival 71 Demonstrates Efficacy 71 Cancer Cells 71 Antibody Drug Conjugate 71 Tumor Angiogenesis 71 Completes Enrollment 71 Monoclonal Antibodies 71 Small Molecules 71 Protein Interactions 71 Ligands 71 Induces 71 Drug Metabolism 71 Immune Cell 71 First Patient Dosed 71 Immunomodulatory 71 Therapeutic Targets 71 Avian Flu Vaccine 71 Protease Inhibitor 71 Vaccine Adjuvant 71 Neural Stem Cells 71 BiTE Antibody 71 Initiate Clinical Trial 71 Proteasome 71 Investigational Drug 71 Targeted Therapy 71 Replacement Therapy 71 Epidermal Growth Factor Receptor 71 Genes Involved 71 Signaling Pathways 70 Monoclonal 70 Antisense 70 Milestone Payment 70 Combination Therapy 70 Initiates Dosing 70 Breast Cancer Metastasis 70 Oral Calcitonin 70 Phase III Clinical Trial 70 Biomarker Study 70 Tezampanel 70 Inflammatory Markers 70 Preclinical Models 70 Novel Method 70 Single Molecule 70 Ion Channels 70 Nicotine Vaccine 70 Genetic Variation 70 Nanoemulsion 70 Initiates Clinical Trials 70 Transdermal Delivery 70 Demonstrates Significant 70 Previously Treated 70 ARRY # 70 Patients Treated With 70 Single Dose 70 Therapeutic Agents 70 Antiviral Activity 70 Gastric Cancer 70 Anticancer Activity 70 Clinical Trial Data 70 Nucleic Acid 70 Oncolytic 70 Significantly Improves 70 Humanized Anti 70 Prostate Cancer Vaccine 70 See CLINICAL PHARMACOLOGY 70 Autoimmune Diseases 70 Therapeutic Efficacy 70 Brain Cells 70 Novel Approaches 70 Patient Enrollment 70 Psoriasis Drug 70 Vitro Activity 70 Shows Promising 70 Chemoprevention 70 Receptor Signaling 70 Regenerative Cells 70 Rheumatoid Arthritis Drug 70 Analogs 70 Metastatic Melanoma 70 Imaging Technique 70 Transfection 70 Cell Proliferation 70 Attenuates 70 Vaccine Candidate 70 Protein Involved 70 Proves Effective 70 Small Molecule Drug 70 Cardiotoxicity 70 Shows Efficacy 70 Anticancer Compound 69 Study Demonstrates 69 Skeletal Muscle 69 Tumor Microenvironment 69 Molecular Mechanisms 69 Molecular Diagnostic 69 Alfacell proprietary ribonuclease 69 HCV Protease Inhibitor 69 Oral Fingolimod 69 Avian Influenza Vaccine 69 Protease Inhibitors 69 Anti CD# Antibody 69 Oral Insulin 69 Progenitor Cells 69 Allosteric 69 FDA Accepts 69 Epilepsy Drug 69 Anticancer Drugs 69 Amino Acid 69 Investigational Treatment 69 Gene Mutation 69 Histone Deacetylase 69 Demonstrates Potent 69 Contrast Agents 69 Malaria Vaccine 69 Well Tolerated 69 Immunostimulatory 69 Vascular Inflammation 69 Files Patent Application 69 Circulating Tumor Cells 69 Oral Presentations 69 Conjugates 69 Diabetic Nephropathy 69 Crit Rev 69 Anthrax Toxin 69 Appears Safe 69 Hepatocellular Carcinoma 69 Cancer Treatments 69 Romidepsin 69 Abstract Accepted 69 Survival Benefit 69 Advanced Renal Cell 69 Beneficial Effects 69 Universal Flu Vaccine 69 Treatment Regimen 69 Innate Immune 69 Nerve Regeneration 69 Clinical Proteomics 69 Confirms Efficacy 69 Granted Orphan Drug 69 Kinases 69 Postdoctoral Position 69 Hematological Malignancies 69 Patents Covering 69 Autoimmune Disorders 69 Neural Stem Cell 69 Estrogen Receptor 69 Solid Tumor 69 Atopic Dermatitis 69 G Protein Coupled 69 Cathepsin S 69 Announces FDA Clearance 69 Endothelial Cells 69 Tumor Cells 69 Demonstrates Positive 69 Gout Drug 69 Phase III Trial 69 Effectively Treats 69 Receptor Antagonist 69 FDA Clears 69 Cholesterol Lowering Drug 69 Chemokine Receptor 69 Shown Effective 69 Protein Therapeutics 69 Hepatocellular 69 Bazedoxifene 69 Blood Clotting 69 Commences Phase 69 MKC# MKC# PP 69 Hematological Cancers 69 Treating Chronic 69 Molecular Diagnostic Test 69 Demonstrates Ability 69 Metabolic Disorder 69 Polymerase Inhibitor 69 Sapacitabine 69 Antigens 69 Issued Patent 69 FDA Approvals 69 Completes Dosing 69 Nucleoside 69 Cell Adhesion 69 KL4 Surfactant 69 Pathogen Detection 69 Cytotoxic 69 candidates Azedra 69 Transdermal Drug 69 Insulin Resistance 69 Anti Infective 69 Protein Linked 69 Receptors GPCRs 69 IND Filing 69 BioSante Pharmaceuticals Announces 69 Antiviral Drugs 69 Gastrointestinal Disorders 69 Osteoporosis Drug 69 Randomized Double Blind 69 Plasmid DNA 69 Liposomal 69 Refractory Angina 69 Anticancer Agents 69 Transcriptome 68 Pluripotent Stem Cells 68 Awarded Qualifying Therapeutic 68 HDL Mimetic Peptide 68 Anti Inflammatory Drug 68 Nucleic Acids 68 NDA Submission 68 investigational humanized monoclonal antibody 68 Biologics Manufacturing 68 Double Blind Placebo 68 Oral Formulation 68 Cell Differentiation 68 Ridaforolimus 68 Dose Response 68 Tumor Necrosis Factor 68 Aliskiren 68 Begin Clinical Trials 68 Blood Pressure Drug 68 Therapeutic Competitors Companies 68 Novel Small Molecule 68 Sustained Release 68 Presents Positive Preclinical 68 Demonstrates Sustained 68 Phase IIa Clinical Trial 68 Dendrimer 68 Dendritic Cell 68 Potent Antiviral Activity 68 Renal Cell Carcinoma 68 Phase IIb Trial 68 Combination Treatment 68 Lyophilized 68 Clinical Efficacy 68 Pivotal Study 68 Signal Transduction 68 Pooled Analysis 68 Dosage Forms 68 Trodusquemine MSI 68 Gene Expression 68 Anthracycline 68 Pivotal Phase III 68 Patients Suffering 68 Diabetic Neuropathy 68 Novel Antibody 68 Cancer Biomarkers 68 Tumor Targeted 68 Poster Presentations 68 Bone Metastases 68 HER1 68 Antifungal 68 Polymorphisms 68 Adipose Derived Stem Cells 68 Targeted Therapies 68 Topical Treatment 68 Novel Protein 68 Breast Tumors 68 Intravenous Immunoglobulin 68 Analytical Tool 68 Scientists Uncover 68 Gene Linked 68 Pulmonary Arterial Hypertension 68 Bucindolol 68 Initiates Phase 68 Nicotinic 68 Files Investigational 68 Inhaled Liposomal Ciprofloxacin 68 Therapeutic Competitors Report 68 Earns Milestone Payment 68 Biocompatibility 68 Imaging Techniques 68 Novel Treatments 68 Neurodegenerative Disease 68 Arthritis Drug 68 Teva Provides Update 68 Adjuvant Chemotherapy 68 Adenoviral 68 Neurogenesis 68 Dose Ranging Study 68 Enzyme Replacement Therapy 68 Cannabinoid 68 Inhibitor 68 Interferon Alpha 68 Multiple Myeloma Patients 68 Nucleotide 68 Safinamide 68 Interferon Beta 68 Submits IND 68 Metastatic Cancer 68 Ebola Vaccine 68 Genes Identified 68 Gets FDA Clearance 68 Conjugate 68 Controlled Study 68 Tumor Growth 68 Placebo Controlled Trial 68 Nitazoxanide 68 Shows Promise 68 Immune Cells 68 Commercialize 68 Novel Anti Inflammatory 68 targeted radiotherapeutic 68 Innate Immunity 68 Inflammatory Response 68 Identifies Potential 68 Naturally Occurring 68 Quantum Dots 68 Prognostic Factors 68 Companion Diagnostic 68 Rotavirus Vaccine 68 Disease Modifying 68 Receives Patent 68 Influenza Virus 68 Meta Analysis 68 Crystallographic 68 Diagnostic Tests 68 Cytotoxicity 68 Incretin 68 anionic backbone 68 Pathway Inhibitor 68 Treatment Resistant 68 Annexin A5 68 Epithelial 68 HER2 Positive 68 Human Neural Stem 68 Microfluidic Devices 68 Myelodysplastic Syndromes 67 Potent Inhibitor 67 Migraine Drug 67 Progenitor Cell 67 Preclinical Testing 67 Benign Prostatic Hyperplasia 67 Proven Effective 67 Drug Resistant 67 GRAS Status 67 Anti Angiogenesis 67 Novel Therapeutics 67 Efficacy Trial 67 Presents Preclinical 67 Improves Outcomes 67 Molecular Evolution 67 Epitopes 67 Contrast Agent 67 Immune Therapy 67 Vaccine Protects Against 67 Improve Survival 67 Cancer Therapies 67 Gene Variation 67 Interferon Gamma 67 Subunit 67 Demonstrated Significant 67 Tumor Suppressor Gene 67 Prognostic Value 67 Phase 1b Clinical Trial 67 Kidney Function 67 Atypical Antipsychotic 67 Intracellular 67 Initiates Phase 2b 67 Non Invasive 67 Technological Advances 67 Investigational Agent 67 Patent Issued 67 Lipid Metabolism 67 Treatment Reduces 67 Pharmaceuticals Initiates 67 Oral Mucositis 67 Inhibitors 67 Potent Anti 67 Hepatitis C Virus 67 Gene Expression Profiling 67 Dehydrogenase 67 Gamma secretase 67 Eculizumab 67 Fibroblast 67 Phage Display 67 Combination REOLYSIN R 67 Cytochrome P# 67 Pharmacodynamics 67 Tumor Suppressor 67 Seasonal Influenza Vaccine 67 Preclinical Evaluation 67 Cholesterol Drug 67 Inhaled Corticosteroids 67 Obtains Exclusive License 67 Prolongs Life 67 Antithrombin 67 Genotyping Test 67 Parathyroid Hormone 67 molecular imaging radiopharmaceutical 67 II Clinical Trial 67 Bosutinib 67 MEK Inhibitor 67 Cancer Vaccine 67 Prostate Cancer Patients 67 DiLA2 67 Hypercholesterolemia 67 Fondaparinux 67 Expanded Indication 67 Anti Inflammatory Drugs 67 Chemotherapeutic 67 Hematopoietic 67 Immunogenicity 67 Mesenchymal Stem Cells 67 Clinical Trial Evaluating 67 Announces Publication 67 Human Monoclonal Antibodies 67 Advanced Melanoma 67 Taxane 67 Trastuzumab DM1 67 Fungal Infections 67 Novel Peptide 67 Clinical Validation 67 Protein Function 67 Mammalian Cells 67 Protease 67 Maribavir 67 Novel Compound 67 Somatostatin 67 Initiate Phase 67 accumulate preferentially 67 Novel Compounds 67 Adenoma 67 Hepatic Encephalopathy 67 Holds Promise 67 Peripheral Blood 67 Angiotensin Converting Enzyme 67 Viral Suppression 67 Stem Cell Transplants 67 Deforolimus 67 Therapeutic Protein 67 Oxidative Stress 67 Bacterial Cell 67 Testosterone Gel 67 Antisense Oligonucleotides 67 Commonly Used 67 Receives Fast Track 67 Test Detects 67 Phase Ib Clinical Trial 67 Pathogenesis 67 Drug Formulation 67 Adjunctive Therapy 67 Dose Escalation Study 67 FOLOTYN ® 67 Epitope 67 Announce License Agreement 67 Receive Milestone Payment 67 Diabetic Foot Ulcer 67 Prospective Randomized 67 Leukemia Cells 67 Commercialize Novel 67 Zinc Finger Nucleases 67 Subtypes 67 Significantly Improved 67 AVI BioPharma Announces 67 Doripenem 67 Preclinical Efficacy 67 Infected Patients 67 Personalized Immunotherapy 67 Submits Response 67 Bioresorbable 67 Statin Therapy 67 Self Assembled 67 TB Vaccine 67 Therapeutic Proteins 67 Faropenem 67 Accelerate Commercialization 67 Genes Linked 67 Glucocorticoid 67 Integrase 67 Secondary Hyperparathyroidism 67 Demonstrates Statistically Significant 67 Gene Expression Analysis 67 Radiopharmaceutical 67 Begins Dosing 67 DOR BioPharma Announces 67 Preclinical Studies 66 Phenotypes 66 Migraine Treatment 66 potently inhibit 66 Receives FDA Clearance 66 Biosynthesis 66 Retinoic Acid 66 Phase III Clinical Trials 66 Drug Combo 66 Dose Escalation 66 product platforms AZX# 66 Viral Infections 66 Histone 66 Announce Collaboration Agreement 66 Fabry Disease 66 Thyroid Hormone 66 Drug Fails 66 Phenotyping 66 Immunogenic 66 NS5A 66 MicroRNA 66 Researchers Uncover 66 Pharmacokinetics 66 Fast Skeletal Troponin 66 Phase 2b Study 66 Soft Tissue Sarcoma 66 Mucosal 66 Macromolecular 66 Optical Sensors 66 TNF Alpha 66 Reduced Risk 66 Locked Nucleic Acid LNA 66 Cardiac Function 66 Structure Function 66 Protein Kinase C 66 Spider Silk 66 IMiDs ® 66 Cancer Immunotherapy 66 Milestone Payments 66 lexidronam injection 66 Fast Track Status 66 First Patient Enrolled 66 Generic Version 66 Prove Effective 66 Morpholino 66 Submits Biologics License Application 66 Renal Cancer 66 Mg Usa 66 Announces Poster Presentations 66 Induced Pluripotent Stem Cells 66 Tumor Cell 66 lead molecular radiotherapeutic 66 Levels Linked 66 Expression Profiling 66 Biopharmaceutical Industry 66 PROSTASCINT R 66 Pegylated 66 Prophylactic Treatment 66 Smallpox Vaccine 66 PI3K/mTOR 66 Hormonal Therapy 66 microRNA Therapeutics 66 XL# XL# 66 Schizophrenia Treatment 66 Nuvelo Announces 66 AAG geldanamycin analog 66 Dapagliflozin 66 Dry Powder Inhaler 66 Unresectable 66 RNA Interference RNAi 66 Randomized Trials 66 Controlled Clinical Trial 66 Tumor Response 66 Minimally Invasive Treatment 66 Myolimus 66 IL# PE#QQR 66 Schizophrenia Drug 66 iPS Cells 66 Phase III Trials 66 Generic Versions 66 Disease Progression 66 Patent Broadly Covering 66 Glycosylation 66 Immune Mediated 66 proteasome inhibitor 66 Functionalized 66 Study Sheds Light 66 Genetic Mutation 66 Cytometry 66 humanized monoclonal 66 Liprotamase 66 orally administered inhibitor 66 Hepatitis B Vaccine 66 Bortezomib 66 protein tyrosine phosphatase 1B 66 NPC 1C 66 Endovascular Treatment 66 Efficacious 66 Endoplasmic Reticulum 66 Slows Progression 66 Pharmacogenomic 66 Radiation Induced 66 highly selective inhibitor 66 Assay Kits 66 Improved Survival 66 Omacetaxine 66 Microplate Readers 66 Patients Receiving 66 Lanthanum Carbonate 66 ALN TTR 66 TKB# 66 Granulocyte Colony Stimulating Factor 66 Molecular Pathogenesis 66 Novel Approach 66 First Patient Treated 66 Tyrosine Kinase Inhibitors 66 Lymphoid 66 Protein Interaction 66 Solid Tumors 66 pan HDAC inhibitor 66 Mylan Receives Approval 66 Macrocyclic 66 Further Validates 66 Initiate Phase III 66 Nasal Powder 66 Homspera TM 66 Polymerase 66 Cyclooxygenase 2 66 Detect Cancer 66 Trial Evaluating 66 Neuroprotective 66 Intellectual Property Portfolio 66 Apoptotic 66 Advanced Colorectal Cancer 66 Fixed Dose Combination 66 Chronic Inflammation 66 Lung Cancer Trial 66 Sign Licensing Agreement 66 Cholesterol Lowering 66 selective inhibition 66 Novel Anticancer 66 Stem Cell Treatment 66 Cell Transplants 66 familial amyloidotic polyneuropathy FAP 66 Lung Cancer Survival 66 Prodrugs 66 Reduces Risk 66 Phospholipase A2 66 Embryonic Stem Cells 66 Neurotransmitter 66 Genomic Analysis 66 peptidic compound 66 Cognitive Deficits 66 Gene Variant 66 Virus Infection 66 Nanopore 66 CYT# potent vascular disrupting 66 Fragment Based 66 Randomized Clinical Trial 66 Nano Scale 66 Lowers Risk 66 Transcriptional 66 Glatiramer Acetate 66 Phase III Pivotal 66 Quantitation 66 uricase 66 Antiviral Therapy 66 Beta Blocker 66 Allogeneic 66 TÎ ² 4 66 Xcytrin R 66 Cell Signaling 66 Unfractionated Heparin 66 OTCBB PWRM.OB 66 Physiology Seminar 66 Commence Phase 66 Randomized Double blind 66 VentiRx Pharmaceuticals 66 Recurrent Breast Cancer 66 Liver Toxicity 66 Nereus Pharmaceuticals 66 Gene Variants 66 Tissue Repair 66 Study Validates 66 Plaque Psoriasis 66 Protein Structure 66 DNA methyltransferase inhibitors 66 Block Copolymer 66 Influenza Vaccine Production 66 Obtains License 66 Therapy Improves 66 Pivotal Phase 66 Autologous Stem Cell Transplantation 65 HDAC Inhibitors 65 Pandemic Influenza Vaccine 65 novel peptide 65 Fixed Dose 65 Androgen Receptor 65 Long Term Efficacy 65 matrix metalloproteases 65 Sangamo BioSciences Announces 65 Brain Tumors 65 Muscarinic 65 Severe Sepsis 65 Integrase Inhibitor 65 Malignancies 65 Renal Cell Cancer 65 Hematopoietic Stem Cells 65 Brain Metastases 65 Effective Treatments 65 Membrane Protein 65 Pandemic Influenza Vaccines 65 SBIR Grant 65 NMDA Receptor 65 Ribosome 65 Helps Predict 65 Awarded Patent 65 Laryngeal Cancer 65 Clinical Evaluation 65 oncolytic virus therapies 65 Metabolites 65 Emerging Therapies 65 Kidney Transplant Patients 65 Randomized Controlled Trials 65 Versus Placebo 65 Biomaterial 65 J Clin 65 Anti Phospholipid Therapy 65 Hepatitis C Infection 65 Pafuramidine 65 Provides Update Regarding 65 Biomarker Discovery 65 non nucleoside inhibitor 65 selective kinase inhibitor 65 Breast Cancer Recurrence 65 Tyrosine Kinase 65 Receives SFDA Approval 65 Adjuvant Treatment 65 Pertuzumab 65 Neoadjuvant Chemotherapy 65 Factor VIIa 65 RNA Amplification 65 Rigel R# 65 Self Assembling 65 Mg Uk 65 P#Y# [001] 65 Tuberculosis Vaccine 65 Highly Selective 65 Adjuvant Therapy 65 Alvine Pharmaceuticals 65 Adult Stem Cell Therapy 65 Hospital Acquired Pneumonia 65 Soluble CD# 65 Relapsing Multiple Sclerosis 65 Nanofiber 65 Cocaine Addiction 65 Archexin 65 Hematologic Malignancies 65 Potentially Fatal 65 Provides Clues 65 targeted antifolate 65 Brain Function 65 Glaucoma Treatment 65 Excretion 65 Ercole Biotech 65 Upregulation 65 Receives Complete Response 65 Genetic Testing 65 Total Knee Arthroplasty 65 Secretion 65 RNA Therapeutics 65 Prostate Cancer Treatment 65 Inhibitory 65 Pharmacyclics Announces 65 Nitric Oxide Synthase 65 Multicenter Randomized 65 SIX RO ROG 65 Macrolide 65 antisense inhibitors 65 Rheumatoid Arthritis Patients 65 Electroporation 65 Neuroprotective Effects 65 candidates Azedra TM 65 Annu Rev 65 Hypertensive Patients 65 Treatment Naïve 65 Phosphatase 65 Voreloxin 65 Study Showed 65 ALN HPN 65 Aneurysm Repair 65 Abdominal Fat 65 PRN FDA Approves 65 Glycoprotein 65 Idenix Novartis 65 chimeric monoclonal antibody 65 Toxicogenomics 65 Maven Semantic 65 Data Suggest 65 Nanocomposite 65 taxane derivative 65 TNF Blockers 65 Begins Shipment 65 fosbretabulin 65 Flamel Technologies Announces 65 Pegloticase 65 Newly Diagnosed 65 Blood Thinner 65 Immunotherapeutics 65 Tissue Engineered 65 Human Antibody 65 Autoimmunity 65 Submits Supplemental 65 Tigecycline 65 Epithelial Cell 65 Polymeric 65 Skin Cells 65 Islet Transplantation 65 Early Diagnosis 65 Asthma COPD 65 AFREZZA TM 65 receptor modulators 65 MEK inhibitor 65 selective immunoproteasome inhibitor 65 pathophysiological effects 65 Platelet Derived Growth 65 Announces Initiation 65 Multiple Ascending Dose 65 Photochemistry 65 Erectile Dysfunction Drug 65 Reductase 65 Statistically Significant 65 Receptor Antagonists 65 Microtubule 65 Synthetic Chemistry 65 oral prodrug 65 Biologic Therapy 65 PEG SN# 65 Anthrax Vaccine 65 Neuroendocrine Tumors 65 Blinatumomab 65 siRNA binds 65 Localized Prostate Cancer 65 Advanced Prostate Cancer 65 Glufosfamide 65 Myocardial Ischemia 65 X Chromosome 65 Valortim TM 65 Carfilzomib 65 Nanoparticle 65 Cervical Dysplasia 65 Controlled Trial 65 Hedgehog Pathway 65 Slow Progression 65 Locked Nucleic Acid 65 Polymorphism 65 hyaluronidase enzyme 65 Asthma Treatment 65 Thin Film Solar Cells 65 Newly Identified 65 Ovarian Cancer Treatment 65 Vildagliptin 65 Breast Tumor 65 Eukaryotic 65 Eluting Stent 65 Biochip 65 Announces Presentation 65 Vertebral Fractures 65 Secretory 65 Impairs 65 Genetic Variations 65 Biopharmaceutical Manufacturing 65 Intravenous Human 65 Cellular Immunology 65 Vivo Imaging 65 Chemotherapy Regimen 65 Squalamine 65 Enrolls First 65 Announce Merger Agreement 65 Reduces Mortality 65 CD# CEA